| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 64.75B | 64.12B | 64.83B | 75.07B | 64.95B | 50.38B |
| Gross Profit | 18.49B | 18.16B | 19.51B | 25.69B | 18.43B | 13.34B |
| EBITDA | 6.24B | 7.04B | 9.04B | 14.29B | 10.11B | 6.41B |
| Net Income | 310.00M | 260.00M | 2.77B | 7.37B | 4.77B | 2.03B |
Balance Sheet | ||||||
| Total Assets | 141.74B | 141.37B | 129.57B | 112.77B | 94.99B | 81.34B |
| Cash, Cash Equivalents and Short-Term Investments | 25.83B | 26.64B | 32.55B | 29.65B | 22.92B | 19.33B |
| Total Debt | 46.06B | 44.71B | 31.48B | 17.03B | 6.58B | 4.41B |
| Total Liabilities | 63.71B | 63.26B | 50.99B | 39.05B | 27.89B | 19.80B |
| Stockholders Equity | 78.03B | 78.11B | 78.57B | 73.72B | 67.10B | 61.53B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -16.97B | -10.74B | -3.07B | 1.22B | 2.94B |
| Operating Cash Flow | 0.00 | 8.10B | 7.09B | 8.69B | 5.97B | 5.29B |
| Investing Cash Flow | 0.00 | -23.94B | -17.40B | -12.93B | -5.92B | -2.70B |
| Financing Cash Flow | 0.00 | 11.25B | 12.29B | 8.05B | 1.25B | 410.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥6.88T | 59.16 | 8.95% | 1.88% | 2.88% | 28.76% | |
72 Outperform | ¥64.05B | 6.34 | 2.45% | 2.19% | 5.79% | 193.94% | |
67 Neutral | ¥3.97T | 15.03 | ― | 1.41% | 7.73% | -1.93% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
60 Neutral | ¥138.34B | 11.45 | ― | 2.18% | -0.93% | -45.03% | |
56 Neutral | ¥559.74B | 15.62 | ― | 2.57% | 4.81% | -49.43% | |
45 Neutral | ¥1.16B | -3.17 | ― | 3.16% | -10.07% | -133.40% |